Skeletal and Non-skeletal Phenotypes in Children with Osteogenesis Imperfecta.
Dentinogenesis imperfecta
Malocclusion
Muscle weakness
Osteogenesis imperfecta
Short stature
Journal
Calcified tissue international
ISSN: 1432-0827
Titre abrégé: Calcif Tissue Int
Pays: United States
ID NLM: 7905481
Informations de publication
Date de publication:
21 Aug 2024
21 Aug 2024
Historique:
received:
14
05
2024
accepted:
12
08
2024
medline:
21
8
2024
pubmed:
21
8
2024
entrez:
21
8
2024
Statut:
aheadofprint
Résumé
Although fractures are the defining characteristic of osteogenesis imperfecta (OI), the disorder affects many tissues. Here we discuss three facets of the OI phenotype, skeletal growth and development, skeletal muscle weakness and the dental and craniofacial characteristics. Short stature is almost universal in the more severe forms of OI and is probably caused by a combination of direct effects of the underlying genetic defect on growth plates and indirect effects of fractures, bone deformities and scoliosis. Recent studies have developed OI type-specific growth curves, which allow determining whether a given child with OI grows as expected for OI type. Impaired muscle function is an important OI-related phenotype in severe OI. Muscles may be directly affected in OI by collagen type I abnormalities in muscle connective tissue and in the muscle-tendon unit. Indirect effects like bone deformities and lack of physical activity may also contribute to low muscle mass and function. Dental and craniofacial abnormalities are also very common in severe OI and include abnormal tooth structure (dentinogenesis imperfecta), malocclusion, and deformities in the bones of the face and the skull. It is hoped that future treatment approaches will address these OI-related phenotypes.
Identifiants
pubmed: 39167113
doi: 10.1007/s00223-024-01276-3
pii: 10.1007/s00223-024-01276-3
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2024. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Références
Garibaldi N, Besio R, Dalgleish R, Villani S, Barnes AM, Marini JC, Forlino A (2022) Dissecting the phenotypic variability of osteogenesis imperfecta. Dis Model Mech. https://doi.org/10.1242/dmm.049398
pubmed: 35575034
pmcid: 9150118
Ekman OJ (1788) Dissertatio medica descriptionem et casus aliquot osteomalaciæ sistens. Upsaliæ, J. Edman, pp 1–73
Sillence DO, Senn A, Danks DM (1979) Genetic heterogeneity in osteogenesis imperfecta. J Med Genet 16:101–116
pubmed: 458828
pmcid: 1012733
Vetter U, Pontz B, Zauner E, Brenner RE, Spranger J (1992) Osteogenesis imperfecta: a clinical study of the first ten years of life. Calcif Tissue Int 50:36–41
pubmed: 1739868
Germain-Lee EL, Brennen FS, Stern D, Kantipuly A, Melvin P, Terkowitz MS, Shapiro JR (2016) Cross-sectional and longitudinal growth patterns in osteogenesis imperfecta: implications for clinical care. Pediatr Res 79:489–495
pubmed: 26539664
Jain M, Tam A, Shapiro JR, Steiner RD, Smith PA, Bober MB, Hart T, Cuthbertson D, Krischer J, Mullins M, Bellur S, Byers PH, Pepin M, Durigova M, Glorieux FH, Rauch F, Lee B, Sutton VR, Consortium MotBBD, Nagamani SCS (2019) Growth characteristics in individuals with osteogenesis imperfecta in North America: results from a multicenter study. Genet Med 21:275–283
pubmed: 29970925
Robinson ME, Rauch D, Glorieux FH, Rauch F (2022) Pubertal growth in osteogenesis imperfecta caused by pathogenic variants in COL1A1/COL1A2. Genet Med 24:1920–1926
pubmed: 35657380
Robinson ME, Rauch D, Glorieux FH, Rauch F (2023) Standardized growth charts for children with osteogenesis imperfecta. Pediatr Res 94:1075–1082
pubmed: 36922619
Ben Amor IM, Roughley P, Glorieux FH, Rauch F (2013) Skeletal clinical characteristics of osteogenesis imperfecta caused by haploinsufficiency mutations in COL1A1. J Bone Miner Res 28:2001–2007
pubmed: 23529829
Ma J, Siminoski K, Alos N, Halton J, Ho J, Cummings EA, Shenouda N, Matzinger MA, Lentle B, Jaremko JL, Wilson B, Stephure D, Stein R, Sbrocchi AM, Rodd C, Lewis VA, Laverdière C, Israels S, Grant RM, Fernandez CV, Dix DB, Couch R, Cairney E, Barr R, Atkinson S, Abish S, Moher D, Rauch F, Ward LM (2019) Impact of vertebral fractures and glucocorticoid exposure on height deficits in children during treatment of leukemia. J Clin Endocrinol Metab 104:213–222
pubmed: 30247635
Rauch D, Robinson ME, Seiltgens C, Sutton VR, Lee B, Glorieux F, Rauch F (2020) Assessment of longitudinal bone growth in osteogenesis imperfecta using metacarpophalangeal pattern profiles. Bone. 140:115547
pubmed: 32730936
pmcid: 7502481
Rauch F, Lalic L, Roughley P, Glorieux FH (2010) Relationship between genotype and skeletal phenotype in children and adolescents with osteogenesis imperfecta. J Bone Miner Res 25:1367–1374
pubmed: 19929435
Barber LA, Abbott C, Nakhate V, Do AND, Blissett AR, Marini JC (2019) Longitudinal growth curves for children with classical osteogenesis imperfecta (types III and IV) caused by structural pathogenic variants in type I collagen. Genet Med 21:1233–1239
pubmed: 30270360
Marini JC, Bordenick S, Heavner G, Rose S, Chrousos GP (1993) Evaluation of growth hormone axis and responsiveness to growth stimulation of short children with osteogenesis imperfecta. Am J Med Genet 45:261–264
pubmed: 8456815
Hoyer-Kuhn H, Hobing L, Cassens J, Schoenau E, Semler O (2016) Children with severe osteogenesis imperfecta and short stature present on average with normal IGF-I and IGFBP-3 levels. J Pediatr Endocrinol Metab 29:813–818
pubmed: 27089405
Lund AM, Muller J, Skovby F (1999) Anthropometry of patients with osteogenesis imperfecta. Arch Dis Child 80:524–528
pubmed: 10332000
pmcid: 1717948
Sanguinetti C, Greco F, De Palma L, Specchia N, Falciglia F (1990) Morphological changes in growth-plate cartilage in osteogenesis imperfecta. J Bone Joint Surg Br 72:475–479
pubmed: 2187879
Lv Z, Liu Y, Jing Y, Zhao Y, Shao C, Fu T, Wang Z, Li G (2022) Impaired proliferation of growth plate chondrocytes in a model of osteogenesis imperfecta. Biochem Biophys Res Commun 613:146–152
pubmed: 35561582
Scheiber AL, Wilkinson KJ, Suzuki A, Enomoto-Iwamoto M, Kaito T, Cheah KS, Iwamoto M, Leikin S, Otsuru S (2022) 4PBA reduces growth deficiency in osteogenesis imperfecta by enhancing transition of hypertrophic chondrocytes to osteoblasts. JCI Insight 7:e149636
pubmed: 34990412
pmcid: 8855815
Zieba J, Nevarez L, Wachtell D, Martin JH, Kot A, Wong S, Cohn DH, Krakow D (2023) Altered Sox9 and FGF signaling gene expression in Aga2 OI mice negatively affects linear growth. JCI Insight 8:e171984
pubmed: 37796615
pmcid: 10721276
Horton WA, Rotter JI, Rimoin DL, Scott CI, Hall JG (1978) Standard growth curves for achondroplasia. J Pediatr 93:435–438
pubmed: 690757
Hoover-Fong JE, Schulze KJ, Alade AY, Bober MB, Gough E, Hashmi SS, Hecht JT, Legare JM, Little ME, Modaff P, Pauli RM, Rodriguez-Buritica DF, Serna ME, Smid C, Liu C, McGready J (2021) Growth in achondroplasia including stature, weight, weight-for-height and head circumference from CLARITY: achondroplasia natural history study-a multi-center retrospective cohort study of achondroplasia in the US. Orphanet J Rare Dis 16:522
pubmed: 34949201
pmcid: 8697459
Graff K, Syczewska M (2017) Developmental charts for children with osteogenesis imperfecta, type I (body height, body weight and BMI). Eur J Pediatr 176:311–316
pubmed: 28058531
pmcid: 5321707
Mueller B, Engelbert R, Baratta-Ziska F, Bartels B, Blanc N, Brizola E, Fraschini P, Hill C, Marr C, Mills L, Montpetit K, Pacey V, Molina MR, Schuuring M, Verhille C, de Vries O, Yeung EHK, Semler O (2018) Consensus statement on physical rehabilitation in children and adolescents with osteogenesis imperfecta. Orphanet J Rare Dis 13:158
pubmed: 30201006
pmcid: 6131938
Kruger KM, Caudill A, Rodriguez Celin M, Nagamani SCS, Shapiro JR, Steiner RD, Bober MB, Hart T, Cuthbertson D, Krischer J, Byers PH, Durigova M, Glorieux FH, Rauch F, Sutton VR, Lee B, Rush ET, Smith PA, Harris GF (2019) Mobility in osteogenesis imperfecta: a multicenter north american study. Genet Med 21:2311–2318
pubmed: 30918359
pmcid: 7401984
Carvalho PAF, Regis TS, Faical AVB, Lago R, Terse-Ramos R, Acosta AX (2023) Functional status of individuals with osteogenesis imperfecta: data from a reference center. J Pediatr (Rio J) 99:94–98
pubmed: 35940209
Veilleux LN, Pouliot-Laforte A, Lemay M, Cheung MS, Glorieux FH, Rauch F (2015) The functional muscle-bone unit in patients with osteogenesis imperfecta type I. Bone 79:52–57
pubmed: 26004918
Garman CR, Graf A, Krzak J, Caudill A, Smith P, Harris G (2019) Gait deviations in children with osteogenesis imperfecta type I. J Pediatr Orthop 39:e641–e646
pubmed: 31393309
Takken T, Terlingen HC, Helders PJ, Pruijs H, Van der Ent CK, Engelbert RH (2004) Cardiopulmonary fitness and muscle strength in patients with osteogenesis imperfecta type I. J Pediatr 145:813–818
pubmed: 15580207
Veilleux LN, Lemay M, Pouliot-Laforte A, Cheung MS, Glorieux FH, Rauch F (2014) Muscle anatomy and dynamic muscle function in osteogenesis imperfecta type I. J Clin Endocrinol Metab 99:E356-362
pubmed: 24248189
Coussens M, Lapauw B, Verroken C, Goemaere S, De Wandele I, Malfait F, Banica T, Calders P (2022) Bone mass, density, geometry, and stress-strain index in adults with osteogenesis imperfecta type i and their associations with physical activity and muscle function parameters. J Bone Miner Res 37:2456–2465
pubmed: 36239015
Pouliot-Laforte A, Veilleux LN, Rauch F, Lemay M (2015) Physical activity in youth with osteogenesis imperfecta type I. J Musculoskelet Neuronal Interact 15:171–176
pubmed: 26032209
pmcid: 5133720
Palomo T, Glorieux FH, Schoenau E, Rauch F (2016) Body composition in children and adolescents with osteogenesis imperfecta. J Pediatr 169:232–237
pubmed: 26593106
Montpetit K, Palomo T, Glorieux FH, Fassier F, Rauch F (2015) Multidisciplinary treatment of severe osteogenesis imperfecta: functional outcomes at skeletal maturity. Arch Phys Med Rehabil 96:1834–1839
pubmed: 26140741
Veilleux LN, Darsaklis VB, Montpetit K, Glorieux FH, Rauch F (2017) Muscle function in osteogenesis imperfecta type IV. Calcif Tissue Int 101:362–370
pubmed: 28474170
Gremminger VL, Omosule CL, Crawford TK, Cunningham R, Rector RS, Phillips CL (2022) Skeletal muscle mitochondrial function and whole-body metabolic energetics in the +/G610C mouse model of osteogenesis imperfecta. Mol Genet Metab 136:315–323
pubmed: 35725939
Moffatt P, Boraschi-Diaz I, Bardai G, Rauch F (2021) Muscle transcriptome in mouse models of osteogenesis imperfecta. Bone 148:115940
pubmed: 33812081
Song IW, Nagamani SC, Nguyen D, Grafe I, Sutton VR, Gannon FH, Munivez E, Jiang MM, Tran A, Wallace M, Esposito P, Musaad S, Strudthoff E, McGuire S, Thornton M, Shenava V, Rosenfeld S, Huang S, Shypailo R, Orwoll E, Lee B (2022) Targeting TGF-beta for treatment of osteogenesis imperfecta. J Clin Invest 132:e152571
pubmed: 35113812
pmcid: 8970679
Sinkam L, Boraschi-Diaz I, Svensson RB, Kjaer M, Komarova SV, Bergeron R, Rauch F, Veilleux LN (2023) Tendon properties in a mouse model of severe osteogenesis imperfecta. Connect Tissue Res 64:285–293
pubmed: 36576243
Engelbert RH, Uiterwaal CS, Gerver WJ, van der Net JJ, Pruijs HE, Helders PJ (2004) Osteogenesis imperfecta in childhood: impairment and disability. A prospective study with 4-year follow-up. Arch Phys Med Rehabil 85:772–778
pubmed: 15129402
Pouliot-Laforte A, Lemay M, Rauch F, Veilleux LN (2017) Static postural control in youth with osteogenesis imperfecta type I. Arch Phys Med Rehabil 98:1948–1954
pubmed: 28433416
Rodriguez Celin M, Kruger KM, Caudill A, Murali CN, Nagamani SCS, Smith PA, Harris GF, Members of the brittle bone disorders C (2023) A multicenter study to evaluate pain characteristics in osteogenesis imperfecta. Am J Med Genet A 191:160–172
pubmed: 36271817
Westerheim I, Hart T, van Welzenis T, Wekre LL, Semler O, Raggio C, Bober MB, Rapoport M, Prince S, Rauch F (2024) The IMPACT survey: a mixed methods study to understand the experience of children, adolescents and adults with osteogenesis imperfecta and their caregivers. Orphanet J Rare Dis 19:128
pubmed: 38515144
pmcid: 10956293
Najirad M, Ma MS, Rauch F, Sutton VR, Lee B, Retrouvey JM, Esfandiari S, Members of the BBD (2018) Oral health-related quality of life in children and adolescents with osteogenesis imperfecta: cross-sectional study. Orphanet J Rare Dis 13:187
pubmed: 30359278
pmcid: 6202869
Taqi D, Moussa H, Schwinghamer T, Ducret M, Dagdeviren D, Retrouvey JM, Rauch F, Tamimi F, Members of the B (2021) Osteogenesis imperfecta tooth level phenotype analysis: cross-sectional study. Bone 147:115917
pubmed: 33741542
pmcid: 8278321
Waltimo-Siren J, Tuurala H, Saamaki E, Holst P, Evalahti M, Arponen H (2021) Dental and dentoalveolar dimensions in individuals with osteogenesis imperfecta. Acta Odontol Scand 79:390–395
pubmed: 33587862
Ma MS, Najirad M, Taqi D, Retrouvey JM, Tamimi F, Dagdeviren D, Glorieux FH, Lee B, Sutton VR, Rauch F, Esfandiari S (2019) Caries prevalence and experience in individuals with osteogenesis imperfecta: a cross-sectional multicenter study. Spec Care Dentist 39:214–219
pubmed: 30758072
pmcid: 6402806
Andersson K, Dahllof G, Lindahl K, Kindmark A, Grigelioniene G, Astrom E, Malmgren B (2017) Mutations in COL1A1 and COL1A2 and dental aberrations in children and adolescents with osteogenesis imperfecta - a retrospective cohort study. PLoS ONE 12:e0176466
pubmed: 28498836
pmcid: 5428910
Rauch F, Lalic L, Roughley P, Glorieux FH (2010) Genotype-phenotype correlations in nonlethal osteogenesis imperfecta caused by mutations in the helical domain of collagen type I. Eur J Hum Genet 18:642–647
pubmed: 20087402
pmcid: 2987338
Wise GE (2009) Cellular and molecular basis of tooth eruption. Orthod Craniofac Res 12:67–73
pubmed: 19419449
pmcid: 2702853
Taqi D, Moussa H, Schwinghamer T, Vieira AR, Dagdeviren D, Retrouvey JM, Rauch F, Tamimi F (2021) Missing and unerupted teeth in osteogenesis imperfecta. Bone 150:116011
pubmed: 34020077
Vuorimies I, Arponen H, Valta H, Tiesalo O, Ekholm M, Ranta H, Evalahti M, Makitie O, Waltimo-Siren J (2017) Timing of dental development in osteogenesis imperfecta patients with and without bisphosphonate treatment. Bone 94:29–33
pubmed: 27725317
Kamoun-Goldrat A, Ginisty D, Le Merrer M (2008) Effects of bisphosphonates on tooth eruption in children with osteogenesis imperfecta. Eur J Oral Sci 116:195–198
pubmed: 18471236
Malmgren B, Tsilingaridis G, Monsef-Johansson N, Qahtani ZHA, Dahllof G, Astrom E (2020) Bisphosphonate therapy and tooth development in children and adolescents with osteogenesis imperfecta. Calcif Tissue Int 107:143–150
pubmed: 32451573
pmcid: 7343730
Del Rio CN, Mourelle Martinez MR, Sagastizabal Cardelus B, De Nova Garcia JM (2024) Influence of zoledronic acid and pamidronate on tooth eruption in children with osteogenesis imperfecta. Bone 182:117069
Rizkallah J, Schwartz S, Rauch F, Glorieux F, Vu DD, Muller K, Retrouvey JM (2013) Evaluation of the severity of malocclusions in children affected by osteogenesis imperfecta with the peer assessment rating and discrepancy indexes. Am J Orthod Dentofacial Orthop 143:336–341
pubmed: 23452967
Nguyen HTT, Vu DC, Nguyen DM, Dang QD, Tran VK, Le H, Tong SM (2021) Dentinogenesis imperfecta and caries in osteogenesis imperfecta among vietnamese children. Dent J (Basel) 9:49
pubmed: 33925433
Najirad M, Madathil SA, Rauch F, Sutton VR, Lee B, Retrouvey JM, Esfandiari S, Members of the brittle bone diseases C, (2020) Malocclusion traits and oral health-related quality of life in children with osteogenesis imperfecta: a cross-sectional study. J Am Dent Assoc 151(480–490):e482
Waltimo-Siren J, Kolkka M, Pynnonen S, Kuurila K, Kaitila I, Kovero O (2005) Craniofacial features in osteogenesis imperfecta: a cephalometric study. Am J Med Genet A 133A:142–150
pubmed: 15666304
Semler O, Cheung MS, Glorieux FH, Rauch F (2010) Wormian bones in osteogenesis imperfecta: correlation to clinical findings and genotype. Am J Med Genet A 152A:1681–1687
pubmed: 20583157
Cheung MS, Arponen H, Roughley P, Azouz ME, Glorieux FH, Waltimo-Siren J, Rauch F (2011) Cranial base abnormalities in osteogenesis imperfecta: phenotypic and genotypic determinants. J Bone Miner Res 26:405–413
pubmed: 20721936
Wadanamby S, El Garwany S, Connolly D, Arundel P, Bishop NJ, DeVile CJ, Calder AD, Crowe B, Burren CP, Saraff V, Highly Specialised Service for Severe C, Atypical Osteogenesis I, Offiah AC (2022) Monitoring skull base abnormalities in children with osteogenesis imperfecta - review of current practice and a suggested clinical pathway. Bone 154:116235
pubmed: 34688943
Reznikov N, Dagdeviren D, Tamimi F, Glorieux F, Rauch F, Retrouvey JM (2019) Cone-beam computed tomography of osteogenesis imperfecta types III and IV: three-dimensional evaluation of craniofacial features and upper airways. JBMR Plus 3:e10124
pubmed: 31346560
pmcid: 6636768
Chetty M, Roberts TS, Stephen L, Beighton P (2017) Craniofacial manifestations in osteogenesis imperfecta type III in South Africa. BDJ Open 3:17021
pubmed: 29607091
pmcid: 5831017
Marulanda J, Retrouvey JM, Lee B, Sutton VR, Rauch F, Briner M, Members of the B (2024) Cranio-cervical abnormalities in moderate-to-severe osteogenesis imperfecta - genotypic and phenotypic determinants. Orthod Craniofac Res 27:237–243
pubmed: 37642979
Ludwig K, Seiltgens C, Ibba A, Saran N, Ouellet JA, Glorieux F, Rauch F (2022) Craniocervical abnormalities in osteogenesis imperfecta type V. Osteoporos Int 33:177–183
pubmed: 34350492
Bardai G, Moffatt P, Glorieux FH, Rauch F (2016) DNA sequence analysis in 598 individuals with a clinical diagnosis of osteogenesis imperfecta: diagnostic yield and mutation spectrum. Osteoporos Int 27:3607–3613
pubmed: 27509835
Retrouvey JM, Taqi D, Tamimi F, Dagdeviren D, Glorieux FH, Lee B, Hazboun R, Krakow D, Sutton VR, Members of the BBDC (2019) Oro-dental and cranio-facial characteristics of osteogenesis imperfecta type V. Eur J Med Genet 62:103606
pubmed: 30593885
Farber CR, Reich A, Barnes AM, Becerra P, Rauch F, Cabral WA, Bae A, Quinlan A, Glorieux FH, Clemens TL, Marini JC (2014) A novel IFITM5 mutation in severe atypical osteogenesis imperfecta type VI impairs osteoblast production of pigment epithelium-derived factor. J Bone Miner Res 29:1402–1411
pubmed: 24519609
Dagdeviren D, Tamimi F, Lee B, Sutton R, Rauch F, Retrouvey JM (2019) Dental and craniofacial characteristics caused by the p.Ser40Leu mutation in IFITM5. Am J Med Genet A 179:65–70
pubmed: 30289614
Homan EP, Rauch F, Grafe I, Lietman C, Doll JA, Dawson B, Bertin T, Napierala D, Morello R, Gibbs R, White L, Miki R, Cohn DH, Crawford S, Travers R, Glorieux FH, Lee B (2011) Mutations in SERPINF1 cause osteogenesis imperfecta type VI. J Bone Miner Res 26:2798–2803
pubmed: 21826736
Glorieux FH, Ward LM, Rauch F, Lalic L, Roughley PJ, Travers R (2002) Osteogenesis imperfecta type VI: a form of brittle bone disease with a mineralization defect. J Bone Miner Res 17:30–38
pubmed: 11771667
Selina A, Kandagaddala M, Kumar V, Abraham SSC, Danda S, Madhuri V (2023) SERPINF1 gene variants causing late-onset progressive deforming osteogenesis imperfecta - a study of 18 patients from India. Bone Rep 18:101690
pubmed: 37425194
pmcid: 10323215
Travessa AM, Dias P, Rosmaninho-Salgado J, Aza-Carmona M, Moldovan O, Diaz-Gonzalez F, Godinho F, Romeu JC, Oliveira-Ramos F, do Ceu Barreiros M, Sousa SB, Heath KE, Sousa AB, (2023) Characterization of three adults and an adolescent with osteogenesis Imperfecta type VI and a novel founder SERPINF1 variant. Eur J Med Genet 66:104867
pubmed: 37839784
Morello R, Bertin TK, Chen Y, Hicks J, Tonachini L, Monticone M, Castagnola P, Rauch F, Glorieux FH, Vranka J, Bachinger HP, Pace JM, Schwarze U, Byers PH, Weis M, Fernandes RJ, Eyre DR, Yao Z, Boyce BF, Lee B (2006) CRTAP is required for prolyl 3- hydroxylation and mutations cause recessive osteogenesis imperfecta. Cell 127:291–304
pubmed: 17055431
Marulanda J, Ludwig K, Glorieux F, Lee B, Sutton VR, Retrouvey JM, Rauch F, Members of the BBDC (2022) Craniofacial and dental phenotype of two girls with osteogenesis imperfecta due to mutations in CRTAP. Bone 164:116516
pubmed: 35970273
pmcid: 10408670